EXANE DERIVATIVES - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$148,000
-78.9%
5
-80.0%
0.00%
Q1 2022$703,000
-39.0%
250.0%0.00%
Q4 2021$1,152,000
+40.5%
250.0%0.00%
Q3 2021$820,000
-99.4%
25
-99.4%
0.00%
-100.0%
Q2 2021$146,540,000
+44989.2%
4,364
+48388.9%
0.03%
Q1 2021$325,000
-93.3%
9
-94.6%
0.00%
-100.0%
Q4 2020$4,849,0001670.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders